Gapping down
In reaction to disappointing earnings/guidance: TISI -11%, CMTL -9.4%, SNX -1.1%
M&A news: SLH -2.3% (in reaction to IHS comments on earnings call in which the co said it was not looking to add a competing bid on SLH).
Other news: ZSAN -54.1% (discontinued development of its Daily ZP-PTH treatment for severe osteoporosis; resumed development of its Weekly ZP-PTH product; terminates collaboration with Eli Lilly (LLY)), ESPR -13.8% (following update on ECT-1002 development plan; new wording suggests FDA could require a completed cardiovascular outcomes trial before approval), SNE -2.9% (Nikkei -4% overnight), TM -1.1% (Nikkei -4% overnight)
Analyst comments: ARMH -2.1% (downgraded to Neutral at Natixis Bleichroeder).